NCT05043701RecruitingPhase 1
Individualized Systems Medicine strategy to target cancer stem cells in patients with recurrent Glioblastoma (ISM-GBM)
Individualized Systems Medicine strategy to target cancer stem cells in patients with recurrent Glioblastoma (ISM-GBM)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 23 Feb 2026
Brief summary (registry, in English)
Establishment and feasability evaluation of high-throuhput drug screens of personalized tumor stem cell cultures. Success of generating an individualized treatment selection based on drug screening.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 2 Oct 2024
- Start date
- 21 Mar 2023
- Lead sponsor
- Oslo University Hospital HF
- Diseases
- Glioblastoma
- NCT number
- NCT05043701
- EU CT number
- 2023-510214-11-00
- EudraCT number
- 2017-000052-26
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 15
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Other
- Patients taking part in other clinical trials which could make incusion or follow-up difficult
- Any reason why, in the opinion of the investigator, the patient should not participate.
Who the study is looking for
- Histologically verified glioblastoma
- Must be ambulatory with an ECOG performance status 0-1
- Must be 18 to 70 years of age.
- Adequate bone marrow, liver and heart function
- Signed informed consent and expected cooperation of the patients for the treatment and follow up must be obtained and documented according to ICH GCP, and national/local regulations.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oslo University Hospital HF Coordinator of this site? Confirm its status | Oslo | Norway | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.